109 Results for "

Epoxide Hydrolase

" in MedChemExpress (MCE) Product Catalog:
Products (109)

109 Results for "Epoxide Hydrolase" in MCE Product Catalog:

Cat. No.: HY-E70418
CAS No.: 9048-63-9
Epoxide hydrolase is an enzyme responsible for catalyzing the reaction between epoxides and water, converting epoxide groups into diols. Epoxide hydrolase plays a key role in the metabolism of environmental pollutants and lipids, contributing to detoxification, inflammation responses, and the regulation of cardiovascular system health. Additionally, epoxide hydrolase can be used in asymmetric catalytic reactions, such as the asymmetric ring-opening of epoxides, to produce chiral drug molecules .
loading...
    loading...
14
14 Publications Verification
Cat. No.: HY-101294
CAS No.: 1222780-33-7
Purity:  99.10%
Target:  

Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

TPPU is a soluble epoxide hydrolase (sEH) inhibitor with IC50 values of 37 and 3.7 nM for monkey and human sEH, respectively.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108570
CAS No.: 479413-70-2
Purity:  ≥98.0%
Target:  

Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

AUDA (compound 43) is a potent soluble epoxide hydrolase (sEH) inhibitor with IC50s of 18 and 69 nM for the mouse and human sEH, respectively . AUDA has anti-inflammatory activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-113974
CAS No.: 885012-33-9
Purity:  98.16%
Synonyms: t-AUCB
Target:  

Epoxide Hydrolase

Research Areas:  

Cancer

trans-AUCB (t-AUCB) is a potent, orally active and selective soluble epoxide hydrolase (sEH) inhibitor with IC50s of 1.3 nM, 8 nM, 8 nM for hsEH, mouse sEH and rat sEH, respectively. trans-AUCB has anti-glioma activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19644
CAS No.: 1142090-23-0
Synonyms: GSK 2256294
Target:  

Epoxide Hydrolase

Research Areas:  

Cardiovascular Disease

GSK2256294A (GSK 2256294) is a selective and orally active inhibitor of soluble epoxide hydrolase (sEH). GSK2256294A inhibits recombinant human sEH, rat sEH orthologs and murine sEH orthologs with IC50s of 27, 61 and 189 pM, respectively. GSK2256294A can be used for the research of chronic obstructive pulmonary disease (COPD) and cardiovascular disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128171
CAS No.: 724453-98-9
Purity:  99.67%
Target:  

FLAP Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

Diflapolin is a highly active dual 5-lipoxygenase-activating protein (FLAP)/soluble epoxide hydrolase (sEH) inhibitor with marked anti-inflammatory efficacy and high target selectivity. Diflapolin inhibits 5-LOX product formation in intact human monocytes and neutrophils with IC50s?of? 30 and 170?nM, respectively, and suppressed the activity of isolated sEH (IC50=20?nM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-135653
CAS No.: 1809885-32-2
Purity:  98.13%
Synonyms: BPN-19186
Target:  

Epoxide Hydrolase

Research Areas:  

Neurological Disease

EC5026 (BPN-19186) is a first-in-class, non-opioid and orally active soluble Epoxide Hydrolase (sEH) inhibitor. EC5026 shows efficacy for inflammatory and neuropathic pain .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-124063
CAS No.: 940954-41-6
Purity:  98.01%
Target:  

Epoxide Hydrolase

Research Areas:  

Cardiovascular Disease

BI-1935, a chemical probe, is a potent soluble epoxide hydrolase (sEH) inhibitor. BI-1935 can be used for the research of cardiovascular disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121538
CAS No.: 479413-68-8
Purity:  ≥98.0%
Target:  

Epoxide Hydrolase PPAR

Research Areas:  

Cardiovascular Disease

CUDA is a potent inhibitor of soluble epoxide hydrolase (sEH), with IC50s of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively . CUDA selectively increases peroxisome proliferator-activated receptor (PPAR) alpha activity. CUDA may be valuable for the research of cardiovascular disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0805A
CAS No.: 18649-93-9
Alisol B is a triterpene with diverse biological activities. Alisol B binds human soluble epoxide hydrolase (sEH) with a Ki of 5.97 μM and reduces sEH activity. Alisol B inhibits RANKL-induced JNK phosphorylation, NFATc1 and c-Fos expression, osteoclast formation, mature osteoclast pit-forming and actin ring activity, and SERCA pump activity. Alisol B induces calcium mobilization, CaMKK-AMPK-mTOR pathway activation, autophagic flux, autophagosome formation, G1 phase cell cycle arrest, endoplasmic reticulum stress, unfolded protein responses, and cancer cell apoptosis. Alisol B can be used for the research of hypercalcemia, osteoporosis, rheumatoid arthritis, periodontitis, acute kidney injury, and breast cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W027340
CAS No.: 68729-05-5
Synonyms: 4BSA
Research Areas:  

Cancer

ARM1 (4BSA) is a potent aminopeptidase and epoxide hydrolase inhibitor. ARM1 shows aminopeptidase inhibitory activity with an IC50 7.61 µM and epoxide hydrolase inhibitory activity with an IC50 12.4 µM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121538A
Target:  

Epoxide Hydrolase PPAR

Research Areas:  

Cardiovascular Disease

CUDA disodium is a potent inhibitor of soluble epoxide hydrolase (sEH), with IC50s of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively . CUDA disodium selectively increases peroxisome proliferator-activated receptor (PPAR) alpha activity. CUDA disodium may be valuable for the research of cardiovascular disease .
loading...
    loading...
Cat. No.: HY-B2117
CAS No.: 2430-27-5
Target:  

Epoxide Hydrolase EBV

Research Areas:  

Infection Neurological Disease

Valpromide is an amide derivative of Valproic acid (HY-10585) and an orally active epoxide hydrolase inhibitor that can cross the blood-brain barrier. Valpromide has antiepileptic, anticonvulsant, and antipsychotic effects. Valpromide also exhibits antiviral activity and can inhibit the reactivation of the EBV lytic cycle .
loading...
    loading...
Cat. No.: HY-111151
CAS No.: 913548-29-5
Purity:  99.69%
Synonyms: APAU
AR9281 (APAU) is a potent, selective and orally active soluble epoxide hydrolase (s-EH) inhibitor. AR-9281 can inhibits human sEH (HsEH) and murine sEH (MsEH) with IC50 values of 13.8 nM and 1.7 nM, respectively. AR9281 can be used for the research of inflammation, hypertension and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-114266
CAS No.: 948304-40-3
Purity:  99.88%
Synonyms: t-TUCB
UC-1728 is a potent rabbit soluble epoxide hydrolase (sEH) inhibitor, with an IC50 of 2 nM on rabbit liver.
loading...
    loading...
Cat. No.: HY-126326
CAS No.: 2376322-12-0
Purity:  99.41%
Target:  

Epoxide Hydrolase

Research Areas:  

Metabolic Disease

SWE101 (compound 22 b) is a potent soluble epoxide hydrolase (sEH)-P inhibitor with IC50s of 4 μM and 2.8 μM for human and rat sEH-P, respectively. SWE101 does not inhibit neither hydrolase nor phosphatase activity of the mouse sEH .
loading...
    loading...
Cat. No.: HY-113862
CAS No.: 1028430-42-3
Purity:  ≥99.0%
PHOME is a fluorogenic substrate for sEH. sEH can hydrolyze the epoxy ring in the PHOME substrate. PHOME can be used for fluorescent epoxide hydrolase assay .
loading...
    loading...
Cat. No.: HY-W013989
CAS No.: 2387-23-7
Target:  

Epoxide Hydrolase

Research Areas:  

Cardiovascular Disease

1,3-Dicyclohexylurea (DCU) is an orally active and potent sEH (soluble epoxide hydrolase) inhibitor. Oral Delivery of 1,3-Dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive Rats .
loading...
    loading...
Cat. No.: HY-120494
CAS No.: 1208549-68-1
Purity:  99.62%
Target:  

Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

sEH inhibitor-1 (compound TCPU ) is a potent and oral active inhibitor of sEH (soluble epoxide hydrolase) with IC50s of 0.4 and 5.3 nM in human and murine, respectively .
loading...
    loading...
Cat. No.: HY-146696
CAS No.: 2418576-06-2
Purity:  ≥98.0%
mEH-IN-1 (Compound 62) is a potent microsomal epoxide hydrolase (mEH) inhibitor with the IC50 of 2.2 nM. The mEH is a mammalian α/β-fold hydrolase enzyme, expressed in almost all tissues, hydrolyzes a wide range of epoxide containing molecules. The mEH is mainly localized in the endoplasmic reticulum (ER) of eukaryotic cells. mEH-IN-1 can be used for the research of preeclampsia, hypercholanemia and cancer .
loading...
    loading...